Use of a Disease-Specific Instrument in Economic Evaluations: Mapping WOMAC onto the EQ-5D Utility Index

Author： Xie Feng   Pullenayegum Eleanor M.   Li Shu-Chuen   Hopkins Robert   Thumboo Julian   Lo Ngai-Nung  

Publisher： Blackwell Publishing

ISSN： 1098-3015

Source： Value in Health, Vol.13, Iss.8, 2010-12, pp. : 873-878

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

General Population Reference Values for the French Version of the EuroQol EQ-5D Health Utility Instrument

By Perneger Thomas V.   Combescure Christophe   Courvoisier Delphine S.  

Value in Health, Vol. 13, Iss. 5, 2010-08 ,pp. : 631-635

Blackwell Publishing

Access to resources Recommend Favorite

The Use of Disease-Specific Outcome Measures in Cost-Utility Analysis: The Development of Dutch Societal Preference Weights for the FACT-L Scale

By Lamers Leida M.   Groot Carin A. Uyl-de   Buijt Ivonne  

PharmacoEconomics, Vol. 25, Iss. 7, 2007-01 ,pp. : 591-603

Adis International

Access to resources Recommend Favorite

Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis

By Adams Roisin  

PharmacoEconomics, Vol. 28, Iss. 6, 2010-06 ,pp. : 477-487

Adis International

Access to resources Recommend Favorite

EQ-5D advances in the UK and France

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 591, 2009-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Utilities of the EQ-5D: Transferable or Not?

By Knies Saskia  

PharmacoEconomics, Vol. 27, Iss. 9, 2009-09 ,pp. : 767-779

Adis International

Access to resources Recommend Favorite